- Biden touts climate legacy in landmark Amazon visit
- Biden clears Ukraine for long-range missile strikes inside Russia
- 'Nobody can reverse' US progress on clean energy: Biden
- Biden allows Ukraine to strike Russia with long-range missiles: US official
- Biden clears Ukraine for missile strikes inside Russia
- Ukrainians brave arduous journeys to Russian-occupied homeland
- 'Devil is in the details,' EU chief says of S.America trade deal
- Toll in Tanzania building collapse rises to 13, survivors trapped
- 'Red One' tops N.America box office but could end up in the red
- Biden begins historic Amazon trip amid Trump climate fears
- Macron defends French farmers in talks with Argentina's Milei
- India and Nigeria renew ties as Modi visits
- Typhoon Man-yi weakens as it crosses Philippines' main island
- 迪拜棕榈岛索菲特美憬阁酒店: 五星級健康綠洲
- The Retreat Palm Dubai MGallery by Sofitel: Пятизвездочный велнес-оазис
- The Retreat Palm Dubai MGallery by Sofitel: A five-star wellness Oasis
- Power cuts as Russian missiles pound Ukraine's energy grid
- Biden in historic Amazon trip as Trump return sparks climate fears
- India hails 'historic' hypersonic missile test flight
- Debt-saddled Laos struggles to tame rampant inflation
- India's vinyl revival finds its groove
- Climate finance can be hard sell, says aide to banks and PMs
- Egypt's middle class cuts costs as IMF-backed reforms take hold
- Dinosaur skeleton fetches 6 million euros in Paris sale
- Trump's Republican allies tread lightly on Paris pact at COP29
- China's Xi urges APEC unity in face of 'protectionism'
- Farmers target PM Starmer in protest against new UK tax rules
- UN climate chief urges G20 to spur tense COP29 negotiations
- Philippines warns of 'potentially catastrophic' Super Typhoon Man-yi
- Tens of thousands flee as Super Typhoon Man-yi nears Philippines
- Gabon votes on new constitution hailed by junta as 'turning point'
- Tens of thousands flee as Typhoon Man-yi nears Philippines
- Is Argentina's Milei on brink of leaving Paris climate accord?
- Fitch upgrades Argentina debt rating amid economic pain
- Trump picks Doug Burgum as energy czar in new administration
- At summit under Trump shadow, Xi and Biden signal turbulence ahead
- Xi warns against 'protectionism' at APEC summit under Trump cloud
- Xi, Biden at Asia-Pacific summit under Trump trade war cloud
- Leftist voices seek to be heard at Rio's G20 summit
- Boeing strike will hurt Ethiopian Airlines growth: CEO
- US retail sales lose steam in October after hurricanes
- Spate of child poisoning deaths sparks S.Africa xenophobia
- Comedian Conan O'Brien to host Oscars
- Gore says 'absurd' to hold UN climate talks in petrostates
- Global stocks struggle after Fed signals slower rate cuts
- China tests building Moon base with lunar soil bricks
- Oil execs work COP29 as NGOs slam lobbyist presence
- Gore says climate progress 'won't slow much' because of Trump
- 'Megaquake' warning hits Japan's growth
- Stiff business: Berlin startup will freeze your corpse for monthly fee
'Love hormone'? Not so fast, new study suggests
The "love hormone" oxytocin has long been thought key to behaviours including pairing up with a partner and nurturing offspring, but a new study in prairie voles is raising doubts.
The research found that voles bred to lack functioning receptors for oxytocin were still able to form strong pairs, produce young and nurse -- all behaviours previously believed to depend on the hormone.
Prairie voles are one of the few mammals that mate for life, and are often used to study social behaviours like pair-forming in animals.
In past studies, voles given drugs that stopped oxytocin being processed no longer formed pairs, and mothers failed to produce milk for their young.
Psychiatrist Devanand Manoli and neurobiologist Nirao Shah produced genetically altered prairie voles without working oxytocin receptors, and then observed how the mutant male and female voles behaved.
To their shock, the mutant voles appeared to have no difficulty pairing up with non-genetically altered partners, and mutant females could still deliver and nurse young, unlike those in the drug-driven studies.
"We were certainly surprised," said Manoli, an assistant professor at the University of California, San Francisco.
The results suggest that oxytocin is not the main, or only, driver of activities like partnering or nursing, he said.
"What the genetics reveals is that there isn't a 'single point of failure' for behaviours that are so critical to the survival of the species," he told AFP.
- 'Very complex behaviours' -
That didn't mean there were no differences, however.
Some male mutant voles that paired with ordinary female partners didn't show the aggression towards interloping females that would normally be expected.
And while mutant females produced and nursed litters, some had fewer pups per litter than their counterparts, and fewer of their offspring survived to weaning, the paper published Friday in the journal Neuron explains.
Pups born to mutant mothers also tended to weigh less, suggesting that they were not able to nurse as effectively.
The study only involved pairing of mutant voles with "wild-type" partners, and the researchers said pairings with two mutant partners could produce different results.
Still, as a whole, the findings suggest a different picture of oxytocin's role in several important behaviours.
That could be because animals bred without the receptors developed "other compensatory pathways" that helped them pair up and nurse, said Shah, a professor at Stanford University.
But the researchers suggest it likely means oxytocin is only part of a set of genetic factors that control social behaviour.
"What I think our studies reveal is that there are multiple pathways that regulate these very complex behaviours," said Manoli.
Oxytocin has sometimes been suggested as a way to treat attachment disorders and other neuropsychiatric issues, but there is little settled science on how effective it is.
Now the researchers hope to investigate what other hormones and receptors may be involved in behaviours like pairing and nursing.
"These other pathways might serve as new therapeutic targets," Manoli said.
Ng.A.Adebayo--CPN